Soleus Capital Management, L.P. Nevro Corp Transaction History

Soleus Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $2.93 Million - $3.82 Million	72,000 New	72,000 $3.36 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $1.27 Million - $1.75 Million	-9,589 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $322,903 - $430,802	-2,337 Reduced 19.6%	9,589 $1.66 Million
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $784,254 - $1 Million	-6,874 Reduced 36.56%	11,926 $1.66 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $1.68 Million - $2.44 Million	18,800 New	18,800 $2.25 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $579,116 - $1.19 Million	-8,246 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $630,076 - $969,234	8,246 New	8,246 $969,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.